Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug Discovery

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1786405

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1786405

Dermal Toxicity Testing

PUBLISHED:
PAGES: 198 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Dermal Toxicity Testing Market to Reach US$4.1 Billion by 2030

The global market for Dermal Toxicity Testing estimated at US$2.7 Billion in the year 2024, is expected to reach US$4.1 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Dermal Toxicity Testing Services, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$2.4 Billion by the end of the analysis period. Growth in the Dermal Toxicity Testing Products segment is estimated at 5.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$699.1 Million While China is Forecast to Grow at 7.2% CAGR

The Dermal Toxicity Testing market in the U.S. is estimated at US$699.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$654.6 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.1% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Global Dermal Toxicity Testing Market - Key Trends & Drivers Summarized

Why Is The Demand For Dermal Toxicity Testing Increasing Rapidly?

The global dermal toxicity testing market is experiencing rapid growth due to the rising need for safe and effective skincare, pharmaceuticals, and chemical products. As regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Chemicals Agency (ECHA) impose stringent safety standards, companies must ensure that their products do not cause skin irritation, sensitization, or long-term dermal damage. The cosmetics and personal care industry, in particular, has witnessed a surge in demand for cruelty-free and non-animal-tested products, further driving the adoption of alternative dermal toxicity testing methods. Additionally, increasing consumer awareness of the potential adverse effects of synthetic chemicals has encouraged manufacturers to prioritize rigorous safety evaluations. With the expanding landscape of dermatological research and the rise in skin-related disorders, the demand for comprehensive dermal toxicity testing continues to grow.

How Are Technological Innovations Transforming The Dermal Toxicity Testing Market?

Technological advancements have significantly revolutionized the dermal toxicity testing landscape, introducing more reliable, ethical, and cost-effective solutions. The adoption of in vitro testing methods, such as 3D human skin models, has provided a superior alternative to traditional animal testing, offering higher accuracy in predicting human skin reactions. Additionally, high-throughput screening (HTS) techniques and advanced bioinformatics tools have accelerated toxicity analysis, allowing researchers to assess multiple compounds simultaneously. The integration of artificial intelligence (AI) and machine learning in toxicity prediction has further enhanced data analysis, improving efficiency and precision in toxicity assessment. Furthermore, regulatory bodies are increasingly advocating for in silico (computer-based) modeling techniques, which enable virtual simulations of skin interactions with chemicals. These technological breakthroughs are shaping the future of dermal toxicity testing, ensuring safer and more ethical product development.

What Are The Major Challenges Affecting The Dermal Toxicity Testing Market?

Despite the progress in the field, several challenges continue to affect the growth and standardization of dermal toxicity testing. One of the primary obstacles is the complexity of human skin biology, making it difficult to create universally applicable in vitro models. While alternative methods have made strides in replacing animal testing, regulatory validation and global acceptance of these models remain slow, delaying widespread adoption. Additionally, the high costs associated with advanced testing techniques and the need for skilled professionals pose financial and operational barriers for smaller companies. Moreover, discrepancies in safety regulations across different countries create compliance challenges for multinational businesses, necessitating continuous adaptation to region-specific testing requirements. Addressing these issues through increased regulatory harmonization, investment in research, and cost-effective innovations will be essential for the sustained expansion of the dermal toxicity testing market.

What Factors Are Driving The Growth Of The Dermal Toxicity Testing Market?

The growth in the dermal toxicity testing market is driven by several factors, including rising regulatory scrutiny, increasing consumer demand for safe and ethical products, and advancements in alternative testing methodologies. The growing adoption of in vitro and in silico testing approaches, along with AI-driven predictive modeling, has enhanced the reliability and efficiency of toxicity assessments. Additionally, the expansion of the pharmaceutical, cosmetic, and chemical industries has intensified the need for stringent safety evaluations, propelling market growth. The push for cruelty-free testing, backed by government regulations and advocacy groups, has accelerated the transition away from animal testing methods. Furthermore, increased research funding and collaborations between regulatory agencies and private organizations are fostering the development of innovative dermal toxicity testing solutions. With continuous technological progress and a rising focus on safety, the market is poised for sustained growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Dermal Toxicity Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Dermal Toxicity Testing Services, Dermal Toxicity Testing Products); Testing Method (In-Vitro Testing Method, In-Vivo Testing Method, In-Silico Modeling Testing Method); Test Type (Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests, Phototoxicity Tests); End-Use (Healthcare industry End-Use, Cosmetics and Personal Care Products End-Use, Chemical End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 32 Featured) -

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Catalent, Inc.
  • Charles River Laboratories International, Inc.
  • Covance Inc. (now part of Labcorp)
  • Cyprotex (a subsidiary of Evotec SE)
  • Eurofins Scientific Inc.
  • Evotec SE
  • GE Healthcare
  • Intertek Group plc
  • InVivo Biosystems
  • MatTek Corporation
  • Merck KGaA
  • Promega Corporation
  • Qiagen N.V.
  • QIMA Ltd.
  • Quest Diagnostics Incorporated
  • SGS S.A.
  • Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP30443

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Dermal Toxicity Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Cosmetic and Pharmaceutical Product Safety Throws the Spotlight on Dermal Toxicity Testing
    • Global Regulatory Compliance Requirements Spur Adoption of In Vitro and Alternative Testing Models
    • Shift Away from Animal Testing Strengthens the Business Case for Reconstructed Human Epidermis Models
    • Growth of Personal Care, Chemical, and Agrochemical Sectors Drives Expanded Testing Pipelines
    • Technological Innovation in Skin-on-a-Chip and Microfluidic Models Enhances Accuracy and Scalability
    • Increased Use of Predictive Toxicology and AI-Driven Screening Supports Non-Animal Safety Assessment
    • OECD and REACH Guidelines Shape Standardized Testing Protocols for Global Market Access
    • Emerging Demand for Rapid Toxicity Screening Tools Fuels Investment in High-Throughput Platforms
    • Expansion of Toxicity Testing in Nanomaterials and Biologics Creates Demand for Specialized Protocols
    • Growing Pharmaceutical Outsourcing Trends Drive Use of CROs and Contract Testing Laboratories
    • Consumer Advocacy and Ethical Branding Pressures Encourage Adoption of Cruelty-Free Testing Methods
    • Toxicology Data Integration with Risk Assessment Platforms Enhances Product Development Speed
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Dermal Toxicity Testing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Dermal Toxicity Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Dermal Toxicity Testing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Dermal Toxicity Testing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Dermal Toxicity Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Dermal Toxicity Testing Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Healthcare industry End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Healthcare industry End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cosmetics & Personal Care Products End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Cosmetics & Personal Care Products End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Chemical End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Chemical End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for In-Vitro Testing Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for In-Vitro Testing Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for In-Vivo Testing Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for In-Vivo Testing Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for In-Silico Modeling Testing Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for In-Silico Modeling Testing Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Skin Sensitization Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Skin Sensitization Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Skin Irritation Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Skin Irritation Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Skin Corrosion Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Skin Corrosion Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Phototoxicity Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Phototoxicity Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Dermal Toxicity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 30: USA Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
  • JAPAN
    • Dermal Toxicity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Japan 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
  • CHINA
    • Dermal Toxicity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 54: China Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: China 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
    • TABLE 60: China Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
  • EUROPE
    • Dermal Toxicity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe 6-Year Perspective for Dermal Toxicity Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Europe 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
  • FRANCE
    • Dermal Toxicity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 72: France Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: France 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
  • GERMANY
    • Dermal Toxicity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
  • ITALY
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Italy 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Italy 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
  • UNITED KINGDOM
    • Dermal Toxicity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 96: UK Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: UK 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
    • TABLE 102: UK Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: UK 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Dermal Toxicity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Asia-Pacific 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 120: Rest of World Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Rest of World 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of World 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of World 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!